Avadel Pharmaceuticals Shares Outstanding 2006-2019 | AVDL

Avadel Pharmaceuticals shares outstanding from 2006 to 2019. Shares outstanding can be defined as the number of shares held by shareholders (including insiders) assuming conversion of all convertible debt, securities, warrants and options. This metric excludes the company's treasury shares.
Avadel Pharmaceuticals Annual Shares Outstanding
(Millions of Shares)
2018 37
2017 42
2016 41
2015 44
2014 36
2013 25
2012 25
2011 25
2010 24
2009 24
2008 24
2007 24
2006 24
2005 23
Avadel Pharmaceuticals Quarterly Shares Outstanding
(Millions of Shares)
Q3 2019 37
Q2 2019 37
Q1 2019 37
Q4 2018 37
Q3 2018 37
Q2 2018 37
Q1 2018 39
Q4 2017 42
Q3 2017 41
Q2 2017 42
Q1 2017 43
Q4 2016 41
Q3 2016 41
Q2 2016 41
Q1 2016 41
Q4 2015 43
Q3 2015 41
Q2 2015 40
Q1 2015 43
Q4 2014 39
Q3 2014 39
Q2 2014 38
Q1 2014 28
Q4 2013 26
Q3 2013 25
Q2 2013 25
Q1 2013 25
Q4 2012 25
Q3 2012 25
Q2 2012 25
Q1 2012 25
Q4 2011 25
Q3 2011 25
Q2 2011 25
Q1 2011 25
Q4 2010 25
Q3 2010 24
Q2 2010 24
Q1 2010 24
Q4 2009 24
Q3 2009 24
Q2 2009 24
Q1 2009 24
Q4 2008 24
Q3 2008 24
Q2 2008 24
Q1 2008 24
Q4 2007 24
Q3 2007 24
Q2 2007 24
Q1 2007 24
Q4 2006 24
Q3 2006 24
Q2 2006 24
Q1 2006 24
Q4 2005 23
Q3 2005 24
Q2 2005 22
Q1 2005 23
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $0.221B $0.103B
Avadel Pharmaceuticals plc is a specialty pharmaceutical company. Its product pipeline consists of hospital and paediatrics. Hospital segment provides Bloxiverz(R), Vazculep(R) and Akovaz(TM). Paediatrics segment provides Karbinal (TM) ER, AcipHex(R) Sprinkle and Flexichamber(TM). The company operates primarily in Ireland, USA and France. Avadel Pharmaceuticals plc, formerly known as Flamel Technologies SA, is headquartered in Lyon, France.
Stock Name Country Market Cap PE Ratio
Takeda Pharmaceutical (TAK) Japan $63.527B 10.04
Zoetis (ZTS) United States $57.408B 34.34
Astellas Pharma (ALPMY) Japan $32.261B 16.11
Eisai (ESALY) Japan $20.266B 39.08
UCB SA (UCBJF) Belgium $15.697B 0.00
Grifols, S.A (GRFS) Spain $15.422B 20.21
Merck (MKGAF) Germany $14.921B 20.36
Neurocrine Biosciences (NBIX) United States $10.834B 511.48
Ono Pharmaceutical (OPHLF) Japan $9.450B 20.20
IPSEN SA ADR (IPSEY) France $9.341B 0.00
Ionis Pharmaceuticals (IONS) United States $9.028B 18.28
Recordati Industria Chimica E Farmaceutica S.P.A (RCDTF) Italy $8.638B 0.00
Jazz Pharmaceuticals (JAZZ) Ireland $8.285B 10.58
Sage Therapeutics (SAGE) United States $7.761B 0.00
Catalent (CTLT) United States $7.514B 30.57
Arrowhead Pharmaceuticals (ARWR) United States $6.571B 99.51
Hikma Pharmaceuticals Plc (HKMPF) United Kingdom $5.986B 0.00
Orion OYJ (ORINY) Finland $5.849B 30.12
STADA ARZNEIMI (STDAF) Germany $5.375B 0.00
Hypermarcas (HYPMY) Brazil $4.881B 17.55
United Therapeutics (UTHR) United States $3.915B 0.00
FibroGen (FGEN) United States $3.860B 113.44
Taro Pharmaceutical Industries (TARO) Israel $3.635B 13.29
Nektar Therapeutics (NKTR) United States $3.423B 0.00
Evotec AG (EVTCY) Germany $3.226B 52.78
PTC Therapeutics (PTCT) United States $3.079B 0.00
Heron Therapeutics (HRTX) United States $2.396B 0.00
Xencor (XNCR) United States $2.245B 68.24
Portola Pharmaceuticals (PTLA) United States $2.163B 0.00
Zogenix (ZGNX) United States $2.046B 0.00
Tilray (TLRY) Canada $1.965B 0.00
Pacira Pharmaceuticals (PCRX) United States $1.921B 56.84
Ironwood Pharmaceuticals (IRWD) United States $1.892B 60.33
ChemoCentryx (CCXI) United States $1.704B 0.00
USANA Health Sciences (USNA) United States $1.582B 16.89
Corcept Therapeutics (CORT) United States $1.554B 18.89
Enanta Pharmaceuticals (ENTA) United States $1.252B 28.58
CLINIGEN GP (CLIGF) United Kingdom $1.244B 0.00
Theravance Biopharma (TBPH) Cayman Islands $1.233B 0.00
AMNEAL PHARMACEUTICALS, INC (AMRX) United States $1.208B 8.24
Endo (ENDP) Ireland $1.132B 2.08
ArQule (ARQL) United States $1.100B 0.00
Karyopharm Therapeutics (KPTI) United States $1.046B 0.00
Spectrum Pharmaceuticals (SPPI) United States $1.033B 0.00
Radius Health (RDUS) United States $1.009B 0.00
Aerie Pharmaceuticals (AERI) United States $0.884B 0.00
Aurinia Pharmaceuticals Inc (AUPH) Canada $0.752B 0.00
Akebia Therapeutics (AKBA) United States $0.722B 0.00
Collegium Pharmaceutical (COLL) United States $0.701B 0.00
Flexion Therapeutics (FLXN) United States $0.697B 0.00
TherapeuticsMD (TXMD) United States $0.640B 0.00
Translate Bio (TBIO) United States $0.600B 0.00
ImmunoGen (IMGN) United States $0.533B 0.00
Ardelyx (ARDX) United States $0.506B 0.00
Organogenesis Holdings (ORGO) United States $0.470B 0.00
Catalyst Pharmaceuticals (CPRX) United States $0.470B 57.00
Crinetics Pharmaceuticals (CRNX) United States $0.462B 0.00
Dermira (DERM) United States $0.450B 0.00
Concordia (CXRXF) Canada $0.444B 0.00
Molecular Templates (MTEM) United States $0.441B 0.00
Aptorum Group (APM) Hong Kong, SAR China $0.440B 0.00
Harpoon Therapeutics (HARP) United States $0.438B 0.00
DURECT (DRRX) United States $0.423B 0.00
BioCryst Pharmaceuticals (BCRX) United States $0.421B 0.00
BioSpecifics Technologies Corp (BSTC) United States $0.405B 17.45
Recro Pharma (REPH) United States $0.383B 0.00
Indivior (INVVY) United States $0.379B 1.37
Siga Technologies (SIGA) United States $0.375B 8.57
OptiNose (OPTN) United States $0.374B 0.00
Rigel Pharmaceuticals (RIGL) United States $0.372B 0.00
Lannett Co Inc (LCI) United States $0.357B 4.16
Innate Pharma SA (IPHYF) France $0.339B 0.00
Corbus Pharmaceuticals Holdings (CRBP) United States $0.308B 0.00
KalVista Pharmaceuticals (KALV) United States $0.273B 0.00
Rafael Holdings (RFL) United States $0.268B 0.00
GlycoMimetics (GLYC) United States $0.248B 0.00
Calithera Biosciences (CALA) United States $0.241B 0.00
Xeris Pharmaceuticals (XERS) United States $0.238B 0.00
Jounce Therapeutics (JNCE) United States $0.235B 3.14
Matinas Biopharma Holdings (MTNB) United States $0.221B 0.00
Aquestive Therapeutics (AQST) United States $0.219B 0.00
Ocular Therapeutix (OCUL) United States $0.192B 0.00
Nature's Sunshine Products (NATR) United States $0.190B 32.73
Foamix Pharmaceuticals (FOMX) Israel $0.189B 0.00
Concert Pharmaceuticals (CNCE) United States $0.178B 0.00
Taiwan Liposome (TLC) Taiwan $0.160B 0.00
MEI Pharma (MEIP) United States $0.144B 0.00
AcelRx Pharmaceuticals (ACRX) United States $0.143B 0.00
IMV INC (IMV) Canada $0.141B 0.00
Redhill Biopharma (RDHL) Israel $0.140B 0.00
MARKER THERAPEUTICS, INC (MRKR) United States $0.137B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.120B 0.00
CannTrust Holdings (CTST) Canada $0.111B 0.00
ALLERGY THERAPT (AGYTF) United Kingdom $0.108B 0.00
Cardiome Pharma (CORV) Canada $0.106B 0.00
CV Sciences (CVSI) United States $0.104B 0.00
Oasmia Pharmaceutical AB (OASMY) Sweden $0.100B 0.00
PolarityTE (PTE) United States $0.084B 0.00
MediWound (MDWD) Israel $0.082B 0.00
Otonomy (OTIC) United States $0.079B 0.00
Neos Therapeutics (NEOS) United States $0.079B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.078B 23.32
Champions Oncology (CSBR) United States $0.076B 0.00
La Jolla Pharmaceutical (LJPC) United States $0.076B 0.00
Aclaris Therapeutics (ACRS) United States $0.072B 0.00
Infinity Pharmaceuticals (INFI) United States $0.071B 0.00
Capnia (SLNO) United States $0.071B 0.00
Pharmaxis (PXSLY) Australia $0.065B 0.00
Entasis Therapeutics Holdings (ETTX) United States $0.065B 0.00
SCYNEXIS (SCYX) United States $0.060B 0.00
Genocea Biosciences (GNCA) United States $0.060B 0.00
ASSERTIO THERAPEUTICS, INC (ASRT) United States $0.060B 0.00
Opiant Pharmaceuticals (OPNT) United States $0.058B 0.00
Novan (NOVN) United States $0.056B 0.00
Nivalis Therapeutics (ALPN) United States $0.056B 0.00
CTI BioPharma (CTIC) United States $0.055B 0.00
Natural Alternatives (NAII) United States $0.055B 13.59
Mast Therapeutics (SVRA) United States $0.054B 0.00
Medicure (MCUJF) Canada $0.054B 0.00
RENEURON GP (RNUGF) United Kingdom $0.052B 0.00
AgeX Therapeutics (AGE) United States $0.052B 0.00
Summit Therapeutics (SMMT) United Kingdom $0.047B 0.00
ElectroCore (ECOR) United States $0.045B 0.00
Iterum Therapeutics (ITRM) Ireland $0.044B 0.00
Dipexium Pharmaceuticals (PLXP) United States $0.043B 0.00
Bellicum Pharmaceuticals (BLCM) United States $0.041B 0.00
IsoRay (ISR) United States $0.041B 0.00
Mannatechorporated (MTEX) United States $0.038B 0.00
Opexa Therapeutics (ACER) United States $0.036B 0.00
Adamis Pharmaceuticals (ADMP) United States $0.035B 0.00
Jaguar Animal Health (JAGX) United States $0.034B 0.00
PharmAthene (ALT) United States $0.033B 0.00
Biomerica (BMRA) United States $0.030B 0.00
India Globalization Capital (IGC) United States $0.029B 0.00
Eyegate Pharmaceuticals (EYEG) United States $0.028B 0.00
ProPhase Labs (PRPH) United States $0.025B 0.00
Melinta Therapeutics (MLNT) United States $0.023B 0.00
China SXT Pharmaceuticals (SXTC) China $0.022B 0.00
Bio-Path Holdings (BPTH) United States $0.021B 0.00
Shineco (TYHT) China $0.020B 0.00
NovaBay Pharmaceuticals (NBY) United States $0.017B 0.00
Flex Pharma (SLRX) United States $0.017B 0.00
Regulus Therapeutics (RGLS) United States $0.016B 0.00
Heat Biologics (HTBX) United States $0.016B 0.00
Vical (BBI) United States $0.016B 0.00
VAXART, INC (VXRT) United States $0.015B 0.00
Cyanotech (CYAN) United States $0.014B 0.00
Kitov Pharmaceuticals Holdings (KTOV) Israel $0.014B 0.00
Lipocine (LPCN) United States $0.011B 0.00
HANCOCK JAFFE (HJLI) United States $0.009B 0.00
Achieve Life Sciences (ACHV) United States $0.008B 0.00
Tetraphase Pharmaceuticals (TTPH) United States $0.007B 0.00
RXi Pharmaceuticals (PHIO) United States $0.006B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.005B 0.00
Xenetic Biosciences (XBIO) United States $0.005B 0.00
Can-Fite Biopharma (CANF) Israel $0.005B 0.00
Hemispherx BioPharma (AIM) United States $0.004B 0.00
Onconova Therapeutics (ONTX) United States $0.002B 0.00
Midatech Pharma (MTP) United Kingdom $0.002B 0.00
Cytori Therapeutics Inc (PSTV) United States $0.001B 0.00
Advanced Accelerator Applications S.A (AAAP) France $0.000B 0.00
Forward Pharma (FWP) Denmark $0.000B 0.00